These results suggest that high expression of IDO-1 (except in skin melanoma) and TDO-2 werse often associated with worse prognosis, while high expression of IDO-2 was often associated with better prognosis (with a few exceptions). This evidence concerns the gene IDO1 and cutaneous melanoma.